The project determines the fraction of patients achieving care goals, identifies predictors of disease and treatment response, and studies adverse outcomes like hospitalizations. Additionally, it looks into genetic and microbiome factors influencing cardiometabolic risk. The project started in December 2023, and is expected to be complted by January 2026.
The project is in collaboraiton with the International Institute of Information Technology- Hyderabad, Indian Institute of Technology- Mumbai, and Max Group of Hospitals. This project is sponsored by the Government of Telangana and Intel.